The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Inivata
Leadership - Inivata
Stock and Other Ownership Interests - Inivata
Molecular profiling of advanced pancreatic cancer (PC) patients from a phase I/II study using circulating tumor DNA.
 
Daniel V.T. Catenacci
Honoraria - Amgen; Foundation Medicine; Genentech/Roche; Genmab; Guardant Health; Lilly; NantWorks; OncoPlex Diagnostics; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Genentech/Roche; OncoPlex Diagnostics
Speakers' Bureau - Foundation Medicine; Guardant Health; Lilly; NantWorks
Research Funding - Genentech; OncoPlex Diagnostics
 
Emma Green
Employment - Inivata
Stock and Other Ownership Interests - Inivata
 
Michael Epstein
Employment - Inivata
Stock and Other Ownership Interests - Inivata
 
Greg Jones
Employment - Inivata; MDxHealth
Stock and Other Ownership Interests - MDxHealth
 
Clive D. Morris
No Relationships to Disclose
 
Emily O'Day
No Relationships to Disclose
 
S Lomnicki
No Relationships to Disclose
 
Melissa Maranto
No Relationships to Disclose
 
Theodore G. Karrison
No Relationships to Disclose
 
Hedy L. Kindler
Consulting or Advisory Role - Aduro Biotech; AstraZeneca; Bayer; Celgene; Genentech/Roche; GlaxoSmithKline; MedImmune; Merck; Plexxikon; Verastem
Research Funding - AB Science; Aduro Biotech; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Incyte; Lilly; MedImmune; Merck; Verastem
Expert Testimony - Aduro Biotech